SlideShare ist ein Scribd-Unternehmen logo

Increasing access to medicines

‱Als PPT, PDF herunterladen‱
‱
M
MeTApresents

Increasing access to medicines, presentation by Edith Andrews Annan of World Health Organization (WHO) during the MeTA Ghana, CSO & media orientation workshop, 16 April 2009.

Gesundheit & Medizin
1 von 20
INCREASING ACCESS TO MEDICINES EDITH ANDREWS ANNAN MeTA CSO Meeting 16 th April 2009
Background ,[object Object],[object Object],[object Object],[object Object]
Background ,[object Object],[object Object],[object Object],[object Object],[object Object]
Essential Medicines: The Criteria ,[object Object],[object Object],[object Object],[object Object],[object Object]
Access to essential medicines is fundamental to human rights ,[object Object],[object Object],[object Object],[object Object]
Access ,[object Object],[object Object]
THE FOUR ‘A’S FOR ACCESS ,[object Object],[object Object],[object Object],[object Object],Let’s focus on the affordability of drugs because the principal barrier to access is the price of medicines!
Access in Poor Countries: The Hurdles ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Increasing access to essential medicines: WHO framework for collective action 1. Rational selection 4. Reliable health and supply systems 2. Affordable prices 3. Sustainable financing ACCESS
WHO’s Access Framework ,[object Object],[object Object],[object Object],[object Object],[object Object]
Ghana Governments attempts at improving access ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Key Barriers in country to access to medicines ,[object Object],[object Object],[object Object],[object Object]
Key Barriers in country to access to medicines ,[object Object],[object Object],[object Object]
Critical Analysis of Barriers to Access ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Critical Analysis of Barriers to Access ,[object Object],[object Object],[object Object],[object Object],[object Object]
Critical Analysis of Barriers to Access ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Critical Analysis of Barriers to Access ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Public/Private Partnerships ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Medicines Transparency Alliance/Good Governance for Medicines ,[object Object],[object Object],[object Object],[object Object],[object Object]
Conclusion ,[object Object],[object Object],[object Object],[object Object],[object Object]

Empfohlen

Access To Medicine
Access To MedicineAccess To Medicine
Access To MedicineMeTApresents
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyDivjyot Kaur
 
What can we learn from other countries?
What can we learn from other countries?What can we learn from other countries?
What can we learn from other countries?Health and Care Innovation Expo
 
Healthcare, Medical and Pharmaceutical Market Access Strategies - John Baresk...
Healthcare, Medical and Pharmaceutical Market Access Strategies - John Baresk...Healthcare, Medical and Pharmaceutical Market Access Strategies - John Baresk...
Healthcare, Medical and Pharmaceutical Market Access Strategies - John Baresk...Bare Sky Marketing Healthcare Content Writing Services
 
Pharmacovigilance overview
Pharmacovigilance overviewPharmacovigilance overview
Pharmacovigilance overviewSunil Boreddy Rx
 
Drug Utilization Studies
Drug Utilization StudiesDrug Utilization Studies
Drug Utilization StudiesZarrin Ansari
 
National Drug Policy
National Drug Policy National Drug Policy
National Drug Policy Tarun Kumar Reddy
 
Presentation: Pharmacovigilance – a regulator’s perspective
Presentation: Pharmacovigilance – a regulator’s perspective Presentation: Pharmacovigilance – a regulator’s perspective
Presentation: Pharmacovigilance – a regulator’s perspective TGA Australia
 

Empfohlen

Access To Medicine
Access To MedicineAccess To Medicine
Access To MedicineMeTApresents
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyDivjyot Kaur
 
What can we learn from other countries?
What can we learn from other countries?What can we learn from other countries?
What can we learn from other countries?Health and Care Innovation Expo
 
Healthcare, Medical and Pharmaceutical Market Access Strategies - John Baresk...
Healthcare, Medical and Pharmaceutical Market Access Strategies - John Baresk...Healthcare, Medical and Pharmaceutical Market Access Strategies - John Baresk...
Healthcare, Medical and Pharmaceutical Market Access Strategies - John Baresk...Bare Sky Marketing Healthcare Content Writing Services
 
Pharmacovigilance overview
Pharmacovigilance overviewPharmacovigilance overview
Pharmacovigilance overviewSunil Boreddy Rx
 
Drug Utilization Studies
Drug Utilization StudiesDrug Utilization Studies
Drug Utilization StudiesZarrin Ansari
 
National Drug Policy
National Drug Policy National Drug Policy
National Drug Policy Tarun Kumar Reddy
 
Presentation: Pharmacovigilance – a regulator’s perspective
Presentation: Pharmacovigilance – a regulator’s perspective Presentation: Pharmacovigilance – a regulator’s perspective
Presentation: Pharmacovigilance – a regulator’s perspective TGA Australia
 
Clinical trial
Clinical trialClinical trial
Clinical trialatharshamim
 
Pharma Pricing & Market Access
Pharma Pricing & Market AccessPharma Pricing & Market Access
Pharma Pricing & Market Access3GDR
 
Polypharmacy
PolypharmacyPolypharmacy
PolypharmacySams Pharmacy
 
Data and safety monitoring boards
Data and safety monitoring boardsData and safety monitoring boards
Data and safety monitoring boardsMadhuri Miriyala
 
Hash 3-1.pptx
Hash 3-1.pptxHash 3-1.pptx
Hash 3-1.pptxHashimGulla
 
Health Financing Within the Overall Health System
Health Financing Within the Overall Health SystemHealth Financing Within the Overall Health System
Health Financing Within the Overall Health SystemHFG Project
 
Orphan Drugs
Orphan DrugsOrphan Drugs
Orphan DrugsAshish Bajaj
 
Quality use medicine
Quality use medicineQuality use medicine
Quality use medicineFARAZULHODA
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
PharmacovigilanceFariha Shikoh
 
Clinical Trials: Regulatory & Privacy Issues
Clinical Trials: Regulatory & Privacy IssuesClinical Trials: Regulatory & Privacy Issues
Clinical Trials: Regulatory & Privacy IssuesMichael Swit
 
Dosing in childrens
Dosing in childrensDosing in childrens
Dosing in childrensDr. Ramesh Bhandari
 
Drugs for rare diseases, Orphan Drugs
Drugs for rare diseases, Orphan DrugsDrugs for rare diseases, Orphan Drugs
Drugs for rare diseases, Orphan DrugsDr. Vishal Pawar
 
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyFundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyHitendra Singh
 
Source Documents in Clinical Trials_part1
Source Documents in Clinical Trials_part1Source Documents in Clinical Trials_part1
Source Documents in Clinical Trials_part1Valentyna Korniyenko
 
Pharmaceutical Pricing, Reimbursement & Market Access in France
Pharmaceutical Pricing, Reimbursement & Market Access in FrancePharmaceutical Pricing, Reimbursement & Market Access in France
Pharmaceutical Pricing, Reimbursement & Market Access in FranceMatt Storer
 
Orphan drugs presentation
Orphan drugs presentationOrphan drugs presentation
Orphan drugs presentationAtul Rajpara
 
Medical writing in clinical research
Medical writing in clinical research Medical writing in clinical research
Medical writing in clinical research PatelHemangini2
 
Universal Health Coverage
Universal Health CoverageUniversal Health Coverage
Universal Health CoverageNursing Path
 
Universal health care
Universal health care Universal health care
Universal health care Dr.Hemant Kumar
 
Phases of clinical trial 11.9.14
Phases of clinical trial 11.9.14Phases of clinical trial 11.9.14
Phases of clinical trial 11.9.14DR ANUP PETARE
 
Medicine financing: NHIS and other financing options
Medicine financing: NHIS and other financing optionsMedicine financing: NHIS and other financing options
Medicine financing: NHIS and other financing optionsMeTApresents
 
Governance, transparency and Accountability~ MeTA objectives, approaches and ...
Governance, transparency and Accountability~ MeTA objectives, approaches and ...Governance, transparency and Accountability~ MeTA objectives, approaches and ...
Governance, transparency and Accountability~ MeTA objectives, approaches and ...MeTApresents
 

Weitere Àhnliche Inhalte

Was ist angesagt?

Clinical trial
Clinical trialClinical trial
Clinical trialatharshamim
 
Pharma Pricing & Market Access
Pharma Pricing & Market AccessPharma Pricing & Market Access
Pharma Pricing & Market Access3GDR
 
Data and safety monitoring boards
Data and safety monitoring boardsData and safety monitoring boards
Data and safety monitoring boardsMadhuri Miriyala
 
Hash 3-1.pptx
Hash 3-1.pptxHash 3-1.pptx
Hash 3-1.pptxHashimGulla
 
Health Financing Within the Overall Health System
Health Financing Within the Overall Health SystemHealth Financing Within the Overall Health System
Health Financing Within the Overall Health SystemHFG Project
 
Orphan Drugs
Orphan DrugsOrphan Drugs
Orphan DrugsAshish Bajaj
 
Quality use medicine
Quality use medicineQuality use medicine
Quality use medicineFARAZULHODA
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
PharmacovigilanceFariha Shikoh
 
Clinical Trials: Regulatory & Privacy Issues
Clinical Trials: Regulatory & Privacy IssuesClinical Trials: Regulatory & Privacy Issues
Clinical Trials: Regulatory & Privacy IssuesMichael Swit
 
Drugs for rare diseases, Orphan Drugs
Drugs for rare diseases, Orphan DrugsDrugs for rare diseases, Orphan Drugs
Drugs for rare diseases, Orphan DrugsDr. Vishal Pawar
 
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyFundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyHitendra Singh
 
Source Documents in Clinical Trials_part1
Source Documents in Clinical Trials_part1Source Documents in Clinical Trials_part1
Source Documents in Clinical Trials_part1Valentyna Korniyenko
 
Pharmaceutical Pricing, Reimbursement & Market Access in France
Pharmaceutical Pricing, Reimbursement & Market Access in FrancePharmaceutical Pricing, Reimbursement & Market Access in France
Pharmaceutical Pricing, Reimbursement & Market Access in FranceMatt Storer
 
Orphan drugs presentation
Orphan drugs presentationOrphan drugs presentation
Orphan drugs presentationAtul Rajpara
 
Medical writing in clinical research
Medical writing in clinical research Medical writing in clinical research
Medical writing in clinical research PatelHemangini2
 
Universal Health Coverage
Universal Health CoverageUniversal Health Coverage
Universal Health CoverageNursing Path
 
Universal health care
Universal health care Universal health care
Universal health care Dr.Hemant Kumar
 
Phases of clinical trial 11.9.14
Phases of clinical trial 11.9.14Phases of clinical trial 11.9.14
Phases of clinical trial 11.9.14DR ANUP PETARE
 

Was ist angesagt? (20)

Clinical trial
Clinical trialClinical trial
Clinical trial
 
Pharma Pricing & Market Access
Pharma Pricing & Market AccessPharma Pricing & Market Access
Pharma Pricing & Market Access
 
Polypharmacy
PolypharmacyPolypharmacy
Polypharmacy
 
Data and safety monitoring boards
Data and safety monitoring boardsData and safety monitoring boards
Data and safety monitoring boards
 
Hash 3-1.pptx
Hash 3-1.pptxHash 3-1.pptx
Hash 3-1.pptx
 
Health Financing Within the Overall Health System
Health Financing Within the Overall Health SystemHealth Financing Within the Overall Health System
Health Financing Within the Overall Health System
 
Orphan Drugs
Orphan DrugsOrphan Drugs
Orphan Drugs
 
Quality use medicine
Quality use medicineQuality use medicine
Quality use medicine
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Clinical Trials: Regulatory & Privacy Issues
Clinical Trials: Regulatory & Privacy IssuesClinical Trials: Regulatory & Privacy Issues
Clinical Trials: Regulatory & Privacy Issues
 
Dosing in childrens
Dosing in childrensDosing in childrens
Dosing in childrens
 
Drugs for rare diseases, Orphan Drugs
Drugs for rare diseases, Orphan DrugsDrugs for rare diseases, Orphan Drugs
Drugs for rare diseases, Orphan Drugs
 
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyFundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
 
Source Documents in Clinical Trials_part1
Source Documents in Clinical Trials_part1Source Documents in Clinical Trials_part1
Source Documents in Clinical Trials_part1
 
Pharmaceutical Pricing, Reimbursement & Market Access in France
Pharmaceutical Pricing, Reimbursement & Market Access in FrancePharmaceutical Pricing, Reimbursement & Market Access in France
Pharmaceutical Pricing, Reimbursement & Market Access in France
 
Orphan drugs presentation
Orphan drugs presentationOrphan drugs presentation
Orphan drugs presentation
 
Medical writing in clinical research
Medical writing in clinical research Medical writing in clinical research
Medical writing in clinical research
 
Universal Health Coverage
Universal Health CoverageUniversal Health Coverage
Universal Health Coverage
 
Universal health care
Universal health care Universal health care
Universal health care
 
Phases of clinical trial 11.9.14
Phases of clinical trial 11.9.14Phases of clinical trial 11.9.14
Phases of clinical trial 11.9.14
 

Ähnlich wie Increasing access to medicines

Medicine financing: NHIS and other financing options
Medicine financing: NHIS and other financing optionsMedicine financing: NHIS and other financing options
Medicine financing: NHIS and other financing optionsMeTApresents
 
Governance, transparency and Accountability~ MeTA objectives, approaches and ...
Governance, transparency and Accountability~ MeTA objectives, approaches and ...Governance, transparency and Accountability~ MeTA objectives, approaches and ...
Governance, transparency and Accountability~ MeTA objectives, approaches and ...MeTApresents
 
Governance transparency and accountability
Governance transparency and accountabilityGovernance transparency and accountability
Governance transparency and accountabilityMeTApresents
 
Challenges to improve medicines transparency in Ghana
Challenges to improve medicines transparency in GhanaChallenges to improve medicines transparency in Ghana
Challenges to improve medicines transparency in GhanaMeTApresents
 
Concept and structure of MeTA
Concept and structure of MeTAConcept and structure of MeTA
Concept and structure of MeTAMeTApresents
 
National drug policy.update
National drug policy.updateNational drug policy.update
National drug policy.updateSiham Abdallaha
 
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...Emmanuel Mosoti Machani
 
Arnaud Emerieu, President of the European Social Insurance Platform, Belgium
Arnaud Emerieu, President of the European Social Insurance Platform, BelgiumArnaud Emerieu, President of the European Social Insurance Platform, Belgium
Arnaud Emerieu, President of the European Social Insurance Platform, BelgiumCittadinanzattiva onlus
 
Medicines Transparency In Ghana
Medicines Transparency In GhanaMedicines Transparency In Ghana
Medicines Transparency In GhanaMeTApresents
 
CSO & media orientation workshop
CSO & media orientation workshopCSO & media orientation workshop
CSO & media orientation workshopMeTApresents
 
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...HFG Project
 
WHO Guideline of Medicine Policy.pdf
WHO Guideline of Medicine Policy.pdfWHO Guideline of Medicine Policy.pdf
WHO Guideline of Medicine Policy.pdfPurbanchal University
 
Beyond Scaling Up: Supply chains
Beyond Scaling Up: Supply chainsBeyond Scaling Up: Supply chains
Beyond Scaling Up: Supply chainsIDS
 
Medicines Transparency in Jordan
Medicines Transparency in JordanMedicines Transparency in Jordan
Medicines Transparency in JordanMeTApresents
 
Applying human rights to advocacy campaigns for access to essential medicines...
Applying human rights to advocacy campaigns for access to essential medicines...Applying human rights to advocacy campaigns for access to essential medicines...
Applying human rights to advocacy campaigns for access to essential medicines...MeTApresents
 

Ähnlich wie Increasing access to medicines (20)

Medicine financing: NHIS and other financing options
Medicine financing: NHIS and other financing optionsMedicine financing: NHIS and other financing options
Medicine financing: NHIS and other financing options
 
Governance, transparency and Accountability~ MeTA objectives, approaches and ...
Governance, transparency and Accountability~ MeTA objectives, approaches and ...Governance, transparency and Accountability~ MeTA objectives, approaches and ...
Governance, transparency and Accountability~ MeTA objectives, approaches and ...
 
Governance transparency and accountability
Governance transparency and accountabilityGovernance transparency and accountability
Governance transparency and accountability
 
Mirfin-Mpundu-Session-1B-CCIH-2017
Mirfin-Mpundu-Session-1B-CCIH-2017Mirfin-Mpundu-Session-1B-CCIH-2017
Mirfin-Mpundu-Session-1B-CCIH-2017
 
Challenges to improve medicines transparency in Ghana
Challenges to improve medicines transparency in GhanaChallenges to improve medicines transparency in Ghana
Challenges to improve medicines transparency in Ghana
 
Concept and structure of MeTA
Concept and structure of MeTAConcept and structure of MeTA
Concept and structure of MeTA
 
National drug policy.update
National drug policy.updateNational drug policy.update
National drug policy.update
 
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...
 
Drug Purchasing & Pricing : industry perspective
Drug Purchasing & Pricing : industry perspectiveDrug Purchasing & Pricing : industry perspective
Drug Purchasing & Pricing : industry perspective
 
Arnaud Emerieu, President of the European Social Insurance Platform, Belgium
Arnaud Emerieu, President of the European Social Insurance Platform, BelgiumArnaud Emerieu, President of the European Social Insurance Platform, Belgium
Arnaud Emerieu, President of the European Social Insurance Platform, Belgium
 
Medicines Transparency In Ghana
Medicines Transparency In GhanaMedicines Transparency In Ghana
Medicines Transparency In Ghana
 
CSO & media orientation workshop
CSO & media orientation workshopCSO & media orientation workshop
CSO & media orientation workshop
 
Agha Campaigns Sandra Kiapi
Agha Campaigns Sandra KiapiAgha Campaigns Sandra Kiapi
Agha Campaigns Sandra Kiapi
 
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
 
Scm
ScmScm
Scm
 
WHO PROMOTING rATIONAL USE OF MEDICINES.pdf
WHO PROMOTING rATIONAL USE OF MEDICINES.pdfWHO PROMOTING rATIONAL USE OF MEDICINES.pdf
WHO PROMOTING rATIONAL USE OF MEDICINES.pdf
 
WHO Guideline of Medicine Policy.pdf
WHO Guideline of Medicine Policy.pdfWHO Guideline of Medicine Policy.pdf
WHO Guideline of Medicine Policy.pdf
 
Beyond Scaling Up: Supply chains
Beyond Scaling Up: Supply chainsBeyond Scaling Up: Supply chains
Beyond Scaling Up: Supply chains
 
Medicines Transparency in Jordan
Medicines Transparency in JordanMedicines Transparency in Jordan
Medicines Transparency in Jordan
 
Applying human rights to advocacy campaigns for access to essential medicines...
Applying human rights to advocacy campaigns for access to essential medicines...Applying human rights to advocacy campaigns for access to essential medicines...
Applying human rights to advocacy campaigns for access to essential medicines...
 

Mehr von MeTApresents

MeTA financial systems and reporting
MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reportingMeTApresents
 
Priorities and milestones – The Philippines
Priorities and milestones – The PhilippinesPriorities and milestones – The Philippines
Priorities and milestones – The PhilippinesMeTApresents
 
MeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTApresents
 
Jordan National Priorities And Milestones
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And MilestonesMeTApresents
 
MeTA introduction
MeTA introductionMeTA introduction
MeTA introductionMeTApresents
 
MeTA Core Principles
MeTA Core PrinciplesMeTA Core Principles
MeTA Core PrinciplesMeTApresents
 
MeTA and data disclosure
MeTA and data disclosureMeTA and data disclosure
MeTA and data disclosureMeTApresents
 
MeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTApresents
 
Data disclosure in Zambia
Data disclosure in ZambiaData disclosure in Zambia
Data disclosure in ZambiaMeTApresents
 
MeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTApresents
 
MeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTApresents
 
MeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTApresents
 
Strengthening multi-stakeholder processes
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processesMeTApresents
 
Data disclosure in Jordan
Data disclosure in JordanData disclosure in Jordan
Data disclosure in JordanMeTApresents
 
MeTA International priorities and milestones
MeTA International priorities and milestonesMeTA International priorities and milestones
MeTA International priorities and milestonesMeTApresents
 
MeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTApresents
 
Data disclosure in Ghana
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in GhanaMeTApresents
 
Data disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanData disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanMeTApresents
 
MeTA evaluation and future
MeTA evaluation and futureMeTA evaluation and future
MeTA evaluation and futureMeTApresents
 
MeTA country guidance note
MeTA country guidance noteMeTA country guidance note
MeTA country guidance noteMeTApresents
 

Mehr von MeTApresents (20)

MeTA financial systems and reporting
MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reporting
 
Priorities and milestones – The Philippines
Priorities and milestones – The PhilippinesPriorities and milestones – The Philippines
Priorities and milestones – The Philippines
 
MeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in Peru
 
Jordan National Priorities And Milestones
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And Milestones
 
MeTA introduction
MeTA introductionMeTA introduction
MeTA introduction
 
MeTA Core Principles
MeTA Core PrinciplesMeTA Core Principles
MeTA Core Principles
 
MeTA and data disclosure
MeTA and data disclosureMeTA and data disclosure
MeTA and data disclosure
 
MeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTA priorities and milestones in Zambia
MeTA priorities and milestones in Zambia
 
Data disclosure in Zambia
Data disclosure in ZambiaData disclosure in Zambia
Data disclosure in Zambia
 
MeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTA priorities and milestones in Uganda
MeTA priorities and milestones in Uganda
 
MeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reporting
 
MeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendations
 
Strengthening multi-stakeholder processes
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processes
 
Data disclosure in Jordan
Data disclosure in JordanData disclosure in Jordan
Data disclosure in Jordan
 
MeTA International priorities and milestones
MeTA International priorities and milestonesMeTA International priorities and milestones
MeTA International priorities and milestones
 
MeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTA priorities and milestones in Ghana
MeTA priorities and milestones in Ghana
 
Data disclosure in Ghana
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in Ghana
 
Data disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanData disclosurein Kyrgyzstan
Data disclosurein Kyrgyzstan
 
MeTA evaluation and future
MeTA evaluation and futureMeTA evaluation and future
MeTA evaluation and future
 
MeTA country guidance note
MeTA country guidance noteMeTA country guidance note
MeTA country guidance note
 

KĂŒrzlich hochgeladen

Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original PhotosCall Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photosnarwatsonia7
 
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalorenarwatsonia7
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxGlomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbaisonalikaur4
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipurparulsinha
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbaisonalikaur4
 
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersBook Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersnarwatsonia7
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliRewAs ALI
 
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service LucknowVIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknownarwatsonia7
 
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiNehru place Escorts
 
Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Gabriel Guevara MD
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...Miss joya
 
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000aliya bhat
 
Call Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
Call Girl Lucknow Mallika 7001305949 Independent Escort Service LucknowCall Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
Call Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknownarwatsonia7
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...narwatsonia7
 
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy GirlsCall Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girlsnehamumbai
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Miss joya
 

KĂŒrzlich hochgeladen (20)

Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original PhotosCall Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
 
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxGlomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Servicesauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
 
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersBook Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas Ali
 
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service LucknowVIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
 
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
 
Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
 
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
 
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
 
Call Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
Call Girl Lucknow Mallika 7001305949 Independent Escort Service LucknowCall Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
Call Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
 
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy GirlsCall Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
 

Increasing access to medicines

  • 1. INCREASING ACCESS TO MEDICINES EDITH ANDREWS ANNAN MeTA CSO Meeting 16 th April 2009
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9. Increasing access to essential medicines: WHO framework for collective action 1. Rational selection 4. Reliable health and supply systems 2. Affordable prices 3. Sustainable financing ACCESS
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.

Hinweis der Redaktion

  1. World Health Organization June 9, 2009